(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

LASSIE GENTLE DIABETES CARE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

LASSIE GENTLE DIABETES CARE

ST13

US500000079314138

Classe

9, 10, 42

Pedido

79314138

Registro

6854543

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

30

Atualização mais recente

14/02/2023

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

9, 10, 42

Data de depósito

22/03/2021

Data de registro

27/09/2022

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

27/09/2022

Última transação

27/09/2022

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

5

Tipo de titular

34

Localização do titular

FR

Examinador

CANTONE, KERI H

Unidade examinadora

L40

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

BOYDSENSE

Representantes

Nicholas D. Wells Legends Law Group

Classificação técnica

Classes Nice

Classe 9Classe 10Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Measuring apparatus and instruments for measuring gas concentration; gas sensors and apparatus for measuring volatile organic compounds; dowloadable software for use in data management for medical use; downloadable software for medical use for assisting users with the provided measuring apparatus and instruments; downloadable software for medical monitoringmanagement and organization of patient data; downloadable software for medical monitoringmanaging and organization of patient data; embedded software for a portable breath-detection apparatus used for detecting diabetes and blood sugar levels in individuals; downloadable software and applications for mobile telephonestablet computers and other mobile electronic devicesin the field of preventionmanagement and treatment of diabetes for management and organization of patient data

Classe 10

Sensor for use in medical diagnosis to gather human biometric data; detection apparatus in the nature of sensors and alarms for medical use for patient monitoring; control measurement apparatus for medical usecontrol unit using breath as a fluid to estimate blood sugar values; mobile physiological monitoring apparatus and analysis apparatus for medical usemedical diagnostic instruments for the analysis of body fluid; blood glucose monitoring system; glucose-level monitoring devices for medical purposes; apparatus for analysis of substances in gases for medical use in the nature of a gas sensor for medical use; apparatus for analysis of substances for medical useorganic compounds and biomarkersbody composition analyzers for medical purposes; analytical devices for medical usefor breath analysis; analytical devices for medical usefor breath analysis to estimate blood sugar values; mobile monitoring apparatus and apparatus for analysis for medical usefor breath analysis to estimate blood sugar values

Classe 42

Design and development of softwaredownloadable software and downloadable applications for mobile telephonestablet computers and other mobile electronic devices in the field of preventionmanagement and treatment of diabetes; electronic storage and back-up of information and data in the field of preventionmanagement and treatment of diabetes; design of mobile applications for individuals to recordtrack and generate reports regarding the statustreatment and management of diabetes; provision of scientific research information relating to diabetes via downloadable applications for mobile telephonestablet computers and other mobile electronic devices

Publicações

Histórico de despachos e eventos da marca no USPTO.

30 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

14/02/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

23/01/2023

FIMP

FINAL DISPOSITION PROCESSED

23/01/2023

GPNX

NOTIFICATION PROCESSED BY IB

28/12/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

27/12/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/11/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/11/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/11/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/11/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/11/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

27/09/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

27/09/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/07/2022

PUBO

PUBLISHED FOR OPPOSITION

12/07/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

29/06/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

29/06/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

22/06/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/06/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/05/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/05/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/05/2022

RFNT

REFUSAL PROCESSED BY IB

26/12/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/12/2021

RFRR

REFUSAL PROCESSED BY MPU

06/12/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/11/2021

CNRT

NON-FINAL ACTION WRITTEN

03/11/2021

DOCK

ASSIGNED TO EXAMINER

26/10/2021

MAFR

APPLICATION FILING RECEIPT MAILED

02/07/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

28/06/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

25/06/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace LASSIE GENTLE DIABETES CARE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.